6 months ago
SHC
AnalystsMatthew SykesMatthew Sykes's Stock Forecasts
AnalystsMatthew Sykes
Analyst Ranking
Top 8%
#381 out of 5087 analysts
Average Return
+12.78%
Win Rate
57%84 out of 148
Risk vs Reward
Poor
Good
Matthew Sykes's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Guardant Health IncGH | +225.36% | $28.59 | $93.02 | 2024-11-07 - 2025-10-31 | Strong Buy |
Natera IncNTRA | +200.29% | $40.76 | $122.40 | 2023-10-20 - 2024-10-18 | Strong Buy |
Guardant Health IncGH | +164.71% | $17.06 | $45.16 | 2024-04-15 - 2025-04-14 | Strong Buy |
Natera IncNTRA | +155.84% | $62.64 | $160.26 | 2023-12-29 - 2024-12-27 | Strong Buy |
Natera IncNTRA | +154.88% | $66.00 | $168.22 | 2024-01-30 - 2025-01-29 | Strong Buy |
Matthew Sykes Analyst Color
Get additional color on Matthew Sykes's coverage of popular stocks
2 years ago
PACB
2 years ago
PACB
2 years ago
DNA
Matthew Sykes's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Fortrea Holdings IncFTRE | 4 | Hold | $5.00 | -52.20% | Maintains | 6 months ago |
Cytek Biosciences IncCTKB | 11 | Strong Sell | $3.00 | -23.08% | Maintains | 6 months ago |
10x Genomics IncTXG | 7 | Strong Sell | $6.50 | -52.35% | Maintains | 6 months ago |
Bruker CorpBRKR | 5 | Hold | $45.00 | +15.56% | Maintains | 6 months ago |
Myriad Genetics IncMYGN | 11 | Strong Buy | $8.00 | -0.50% | Maintains | 6 months ago |
Twist Bioscience CorpTWST | 9 | Strong Buy | $48.00 | +45.94% | Maintains | 6 months ago |
Sotera Health CoSHC | 1 | Strong Buy | $17.00 | +2.41% | Upgrades | 6 months ago |
Icon PLCICLR | 4 | Hold | $160.00 | -6.88% | Maintains | 6 months ago |
Neogenomics IncNEO | 8 | Strong Buy | $10.00 | +2.35% | Maintains | 6 months ago |
Revvity IncRVTY | 3 | Strong Buy | $125.00 | +33.56% | Maintains | 6 months ago |
Avantor IncAVTR | 4 | Hold | $14.00 | +18.44% | Downgrades | 6 months ago |
Danaher CorpDHR | 4 | Strong Buy | $240.00 | +11.43% | Maintains | 6 months ago |
Caredx IncCDNA | 10 | Strong Buy | $26.00 | +73.33% | Maintains | 7 months ago |
Charles River Laboratories International IncCRL | 4 | Hold | $170.00 | -5.59% | Downgrades | 7 months ago |
Guardant Health IncGH | 13 | Strong Buy | $56.00 | -39.80% | Maintains | 8 months ago |
Genedx Holdings CorpWGS | 13 | Hold | $80.00 | -41.57% | Maintains | 8 months ago |
Pacific Biosciences Of California IncPACB | 5 | Hold | $1.50 | -35.90% | Maintains | 9 months ago |
Natera IncNTRA | 12 | Strong Buy | $190.00 | -4.49% | Maintains | 9 months ago |
Nautilus Biotechnology IncNAUT | 4 | Strong Sell | $1.75 | +31.58% | Downgrades | a year ago |
Maravai Lifesciences Holdings IncMRVI | 10 | Strong Sell | $4.25 | +35.35% | Downgrades | a year ago |
Veracyte IncVCYT | 5 | Hold | $37.00 | +2.55% | Downgrades | a year ago |
Exact Sciences CorpEXAS | 6 | Strong Buy | $65.00 | +0.48% | Maintains | a year ago |
Iqvia Holdings IncIQV | 2 | Strong Buy | $250.00 | N/A | Maintains | a year ago |
Singular Genomics Systems IncOMIC | 11 | Hold | $6.50 | N/A | Maintains | a year ago |
Quanterix CorpQTRX | 11 | Strong Buy | $24.00 | N/A | Maintains | a year ago |
Mettler Toledo International IncMTD | 5 | Hold | $1,300.00 | N/A | Maintains | a year ago |
Ginkgo Bioworks Holdings IncDNA | 6 | Strong Sell | $12.00 | N/A | Maintains | a year ago |
Thermo Fisher Scientific IncTMO | 3 | Strong Buy | $640.00 | N/A | Maintains | 2 years ago |
Agilent Technologies IncA | 4 | Strong Buy | $145.00 | N/A | Maintains | 2 years ago |
Cue Health IncHLTHQ | 6 | Hold | $0.50 | N/A | Maintains | 2 years ago |
Invitae CorpNVTAQ | 7 | Strong Sell | $0.50 | N/A | Maintains | 2 years ago |
Lumiradx LtdLMDXF | 2 | Hold | $0.75 | N/A | Maintains | 2 years ago |
Olink Holding Ab OLK | 4 | Hold | $18.00 | N/A | Maintains | 3 years ago |
Zymergen IncZY | 2 | Hold | $12.00 | N/A | Downgrades | 4 years ago |
Quotient LtdQTNTQ | 1 | Hold | $5.00 | N/A | Initiates Coverage On | 4 years ago |
Qiagen NvQGEN | 3 | Hold | $53.56 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.